Expert Advice 8 Nov 2024 How to negotiate your job offer in biotech Learn how to be prepared to negotiate your biotech job offer by reading the tips that experts shared with us. November 8, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Nov 2024 Can AI cure Alzheimer’s disease? A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease. “Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the […] November 1, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress. October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2024 Fighting severe epilepsies: A new era for Dravet syndrome treatment? Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline. October 24, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2024 Turning back time with cellular reprogramming: Shift raises $16 million in seed funding As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases. October 21, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment. October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2024 Booster launches to treat neurodegenerative diseases with proteasome activation Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million. October 15, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 11 Oct 2024 How to build your biotech company in 2024 (according to founders) Discover the insight successful biotech founders share with us to build your biotech company – from building your team to attracting funding. October 11, 2024 - 19 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2024 Spinal cord injury: Are we getting closer to a treatment? Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition. October 7, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2024 Resolution Therapeutics raises $85 million to advance its macrophage therapy Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round. October 3, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Oct 2024 Lithuania’s biotech: Six companies to put on your radar Here are six companies at the forefront of Lithuania’s growing biotech scene, showcasing innovations in protein engineering and gene editing. October 1, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email